Versago Vascular Access Obtains $1,650,000 Seed Financing

  • Feed Type
  • Date
    2/25/2016
  • Company Name
    Versago Vascular Access
  • Mailing Address
    375 West Street West Bridgewater, MA 02379 USA
  • Company Description
    Versago is a true platform technology, spanning several fields with its unique design. Our patented technology displaces multiple traditional access applications in Apheresis and Chemotherapy, and opens several new ones such as Total Parenteral Nutrition, CAR-T and Hemodialysis.
  • Website
    http://www.versagovascularaccess.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,650,000
  • Transaction Round
    Seed
  • Proceeds Purposes
    The company’s new funding will be used to further develop the Versago line of port technology, initiate regulatory review and conduct animal testing.
  • M&A Terms
  • Venture Investor
    Primo Medical Group
  • Venture Investor
    Undisclosed

Trending on Xconomy